HD vs MRK: Which Is the Better Buy?

Side-by-side comparison of The Home Depot, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
The Home Depot, Inc. · Consumer Cyclical
$292.18
+44.2% upside to fair value
Med Conviction Grade B High Quality
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
QuantHub Verdict
HD has more upside to fair value (+44.2%). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric HD MRK
Current Price $292.18 $147.17
Fair Value Estimate $421.26 $141.07
Upside to Fair Value +44.2% -4.1%
Market Cap $291.3B $363.5B
Forward P/E — —
EV / EBITDA 14.7x 29.6x
Price / Sales 1.7x 5.5x
Price / FCF 19.2x 22.6x
Revenue Growth YoY +5.7% +5.1%
Gross Margin 33.2% 75.4%
Operating Margin 12.4% 16.7%
Return on Equity 102.7% 6.6%
Dividend Yield 3.18% 2.31%
FCF Yield 5.2% 4.42%
Analyst Consensus Strong Buy Buy
Investment Thesis
HD — The Home Depot, Inc.
The Home Depot is the largest home-improvement retailer in the United States, operating a network of roughly 2,300 stores supported by about 472,400 full-time employees, and serving both do-it-yourself homeowners and professional contractors through stores, homedepot.com, and specialty sites such as blinds.com. The business quality is high: it generates a 102.7% return on equity, a 33.2% trailing…
MRK — Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
Metric HD MRK
Zone Low $315.94 $105.80
Zone High $358.07 $119.91
In Buy Zone? Yes No
← HD Research    MRK Research →    All Research